Haleon ups stake in China joint venture to 88%
27th Sep 2024 10:15
(Sharecast News) - Haleon said on Friday that it has agreed to buy an additional 33% interest in Tianjin TSKF Pharmaceutical - its joint venture in China - from its partners Tianjin Pharmaceutical Group (TPG) and Tianjin Pharmaceutical Da Ren Tang Group Corporation (DRTG) for RMB4,465m (circa£0.5bn).
Read moreLondon close: Stocks slide amid big global selloff
5th Aug 2024 16:46
(Sharecast News) - London's stock markets ended sharply lower on Monday, as part of a broader global market downturn.
Read moreLondon close: Stocks slide as Bank of England trims rates
1st Aug 2024 16:09
(Sharecast News) - London's stock markets ended the day in negative territory on Thursday, as investors digested the Bank of England's decision to cut interest rates for the first time in four years.
Read moreHaleon H1 profits grow despite revenue contraction
1st Aug 2024 10:13
(Sharecast News) - Consumer healthcare business Haleon said on Thursday that profits had grown in the six months ended 30 June, driven by solid H1 sales of its vitamins and oral health products.
Read moreLondon close: Stocks finish choppy day in the red
26th Jun 2024 15:32
(Sharecast News) - London stocks ended in negative territory on Wednesday, influenced by a downturn in retail sales data for June.
Read moreHaleon to sell NRT business outside of the US to Dr Reddy's for £500m
26th Jun 2024 12:49
(Sharecast News) - Haleon said on Wednesday that it has agreed to sell its nicotine replacement therapy (NRT) business outside of the US to Dr Reddy's Laboratories for £500m.
Read moreBerenberg starts coverage of Haleon at 'buy'
5th Jun 2024 08:49
(Sharecast News) - Berenberg initiated coverage of consumer health company Haleon on Wednesday with a 'buy' rating and 407p price target.
Read moreLondon close: Stocks recoup some earlier losses
17th May 2024 15:52
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
Read moreGSK raises £1.25bn from sale of remaining Haleon stake
17th May 2024 07:29
(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.
Read moreGSK to sell entire 4.2% remaining stake in Haleon
16th May 2024 17:02
(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
Read moreLondon close: Stocks fall ahead of US Fed decision
1st May 2024 16:42
(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.
Read moreHaleon makes 'solid start' to FY24
1st May 2024 09:10
(Sharecast News) - Consumer healthcare company Haleon said on Wednesday that it had made a "solid start to the year", posting better-than-expected Q1 profits despite seeing a fall in revenues.
Read moreLondon close: Stocks follow Wall Street into the red
30th Apr 2024 17:08
(Sharecast News) - London markets closed in the red on Tuesday, turning weaker during the afternoon to mirror the decline in Wall Street equities, as investors monitored the start of the Federal Reserve's two-day policy meeting.
Read moreWednesday preview: Federal Reserve, Haleon in focus
30th Apr 2024 13:27
(Sharecast News) - Investors' focus in the middle of the week will be on the U.S. central bank.
Read moreHaleon too shut Maidenhead factory, putting 435 jobs at risk
30th Apr 2024 12:01
(Sharecast News) - Haleon, the British healthcare company behind brands like Sensodyne and Panadol, is expected to announce 435 job cuts over the next two years due to plans to shut its Maidenhead manufacturing plant.
Read more